AI assistant
Sending…
RESMED INC — Director's Dealing 2014
Jan 13, 2014
30071_dirs_2014-01-13_46bec220-ac7d-4be6-99c1-df492057b2e6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-01-09
Reporting Person: FARRELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-09 | ResMed Common Stock | M | 25000 | $21.025 | Disposed | 514876 | Direct |
| 2014-01-09 | ResMed Common Stock | S | 25000 | $48.00 | Disposed | 489876 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-09 | ResMed Common Stock Options | $21.025 | M | 25000 | Disposed | 2014-11-07 | ResMed Common Stock (25000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 200000 | Indirect |
Footnotes
F1: This transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: Represents date options first became exercisable. Options vest 1/4 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29